asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

Treatment Options

Recent Posts in Treatment Options Category

Feb 7 2017

A Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With Relapsed or Refractory Malignant Mesothelioma With BAP1 Loss of Function

Tazemetostat is an investigational drug that kills cancer cells by stopping a gene called EZH2 from working. EZH2 affects how two other genes, INI1 and SMARCA4 work in cells. In early clinical development, tazemetostat has demonstrated clinical ...

Continue Reading...
Dec 16 2016

Study Shows That New Treatment Method May Dramatically Increase the Lifespan of Patients with Malignant Pleural Mesothelioma

A study conducted by a team of researchers from the University of Maryland Medical System, the University of Maryland School of Medicine, the Penn-Presbyterian Medical Center, the University of Pennsylvania and the Hospital of the University of ...

Continue Reading...
Nov 15 2016

An Aspirin a Day May Keep Mesothelioma Away

A recent study reveals that taking an aspirin every day may be effective in preventing or delaying the onset of mesothelioma in persons exposed to asbestos. The Facts Mesothelioma is an aggressive cancer caused by exposure to asbestos affecting over ...

Continue Reading...
May 6 2015

Latest Lung-Sparing Therapies, Patient Resources and "Hollywood Ending" at Pacific Meso Center's 5th International Symposium

The Pacific Meso Center, in conjunction with The Office of Continuing Medical Education of the David Geffen School of Medicine at UCLA, held the 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma on May 2nd, 2015 ...

Continue Reading...
Apr 7 2015

UCLA's Innovative Approach Improves Treatment Options for Patients with Mesothelioma

In the spring 2015 edition of the UCLA quarterly newsletter, Vital Signs, UCLA’s Comprehensive Mesothelioma Program presents their innovative approach to treating this complex and difficult to treat cancer. As one of the early pioneers for the ...

Continue Reading...
Mar 25 2015

UCLA Health Releases New Video Chronicling Treatment of Six-Year Meso Survivor Martha Munoz

On March 23, 2015, UCLA Health released a new video which chronicles the medical treatment of Worthington & Caron, PC client Martha Munoz. Martha was 68 years old when she was diagnosed with malignant pleural mesothelioma in March 2009. Her ...

Continue Reading...
Mar 28 2014

Laparoscopic Cytoreductive Surgery Followed by HIPEC Offers Patients with Peritoneal Mesothelioma Shorter Recovery Time with Fewer Complications

The standard treatment for peritoneal mesothelioma patients eligible for surgery is cytoreductive surgery (CRS) followed immediately by heated intraperitoneal chemotherapy (HIPEC). Traditional surgery involves a large incision made in the abdomen in ...

Continue Reading...
Feb 28 2014

Substance Found in Turmeric Packs Powerful Punch against Mesothelioma

Curcumin, a naturally occurring polyphenol in turmeric, is being studied for its possible application in the treatment and prevention of mesothelioma. Turmeric has long been believed to have anticancer properties due to its antioxidant and ...

Continue Reading...
Jan 9 2014

Recent Study Confirms Effectiveness of Radiation Therapy Following Lung-Sparing Pleurectomy/Decortication Surgery

There has been a long-standing debate over which surgery is more effective for treating malignant pleural mesothelioma (MPM). For many years, a majority of surgeons believed that a radical procedure called Extrapleural Pneumonectomy (EPP), which ...

Continue Reading...
Dec 20 2013

Worthington Supports Innovative Stem Cell Therapy Initiative for Mesothelioma. Donates $100,000 to Pacific Meso Center

Roger Worthington of Worthington & Caron, PC announced today he is donating $100,000 to the Pacific Meso Center (PMC) in Los Angeles, California to help continue their research on the use of modified stem cells to treat patients stricken with ...

Continue Reading...
Oct 11 2013

Lowering Copper Levels in Mesothelioma May Make Standard Treatments More Effective

Researchers at Western Australia’s Curtin University have found promising data to suggest that lowering the amount of copper in the body will improve a patient’s response to treatment for mesothelioma. In previous studies, decreasing the ...

Continue Reading...
Aug 30 2013

New Immunotherapy Compound Anti-CD40 Slows Mesothelioma Tumor Growth After Recurrence

In the September 2013 issue of The Journal of Immunotherapy, researchers from the Western University of Australia published results of a study using a promising new immunotherapy compound and its effects on reoccurring mesothelioma tumors in lab ...

Continue Reading...
Aug 16 2013

Drugs Used to Lower Cholesterol May Prove To Be Viable Mesothelioma Treatment Option

Researchers at Chiba University in Japan recently examined the response of mesothelioma cells when treated with a combination of two statin drugs commonly used to lower cholesterol and paired with a form of vitamin E called gamma tocotrienol (y-T3). ...

Continue Reading...
Jul 7 2013

FDA Issues Approval for Phase 2 Clinical Trial of Potential New Mesothelioma Treatment

The FDA has issued approval for biopharmaceutical company Verastem to begin a Phase 2 clinical study of a new drug for the treatment of malignant pleural mesothelioma. VS-6063 is an orally available, small molecule inhibitor of a crucial signaling ...

Continue Reading...
Mar 1 2013

Green Tea Compound Found to be Effective in Killing Mesothelioma Cells

Green tea is made from the leaves of the Camellia sinensis plant and its history dates back 5000 years. There is an old Chinese legend that says a man, Shien Non Shei, was walking one day when he curiously tasted the juices from a leaf of a plant and ...

Continue Reading...
Feb 20 2013

3rd International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

The office of Continuing Medical Education at the David Geffen School of Medicine at UCLA and The Pacific Meso Center at the Pacific Heart, Lung & Blood Institute is holding the 3rd International Symposium on Lung-Sparing Therapies for Malignant ...

Continue Reading...
Feb 11 2013

Is EPP Superior to Supportive Care in the Treatment of Malignant Pleural Mesothelioma?

The question of whether extrapleural pneumonectomy (EPP) is superior to supportive care, in terms of morbidity, symptom control and survival, in the treatment of patients with malignant pleural mesothelioma (MPM) is examined by reviewing 14 papers ...

Continue Reading...
Sep 20 2012

Thermal Therapy in the Treatment of Malignant Pleural Mesothelioma

Thermal therapy has been used in cancer therapy for decades and hyperthermic chemotherapy perfusion, specifically, has been used in the treatment of mesothelioma but without data as to the optimal conditions. In a study performed at UCLA, doctors ...

Continue Reading...
Sep 19 2012

The Timing of Chemotherapy in the Multimodality Treatment of Malignant Pleural Mesothelioma

Chemotherapy used in multimodality treatment of malignant pleural mesothelioma is typically performed within 4-6 weeks prior to or after surgery, and various strategies have been used with regard to the timing of chemotherapy within a multimodality ...

Continue Reading...
Jun 4 2012

UCLA Mesothelioma Care Employs Lung-sparing Surgery and Unique Treatment Approach

UCLA’s Mesothelioma treatment program focuses on research and experience and has pioneered the use of therapies, such as immunotherapy and cryoablation which have led to significant advances in care. At UCLA, basic science and clinical research ...

Continue Reading...
May 16 2012

2nd Annual Symposium on Lung Sparing Therapies for Malignant Pleural Mesothelioma Brings Together an International Panel of Medical Specialists, Patients and Caregivers

The Pacific Meso Center, in conjunction with The Office of Continuing Medical Education of the David Geffen School of Medicine at UCLA, held the 2nd International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma on May 14, 2012 ...

Continue Reading...
Jan 25 2011

Mesothelioma Patients May Benefit From Second Pemetrexed-based Chemotherapy

A new study conducted by a team of Italian researchers tested the effectiveness of pemetrexed-based chemotherapy (PBC) as a second-line treatment for mesothelioma cancer patients whose cancer shows at least a partial response to initial chemo. PBC is ...

Continue Reading...

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Speak with an Attorney